文献速递骨肌DRMR

验证美国放射学会骨报告与数据系统(Bone-RADS)2023版在传统X线片上诊断附肢骨恶性肿瘤的价值

Validation of American College of Radiology Bone Reporting and Data System (Bone-RADS) Version 2023 for diagnosis of malignant tumors of appendicular bone on conventional radiographs.
PubMed 文献 · Eur J Radiol · 2024-11-28

本研究以病理、影像随访或临床-放射学共识为标准,回顾778例附肢骨原发及继发肿瘤患者的X线与MRI资料,由两位放射科医生按ACR Bone-RADS 2023版评分并分类。Bone-RADS对恶性肿瘤的鉴别能力高(点总分AUC 0.940-0.957,分类AUC 0.895-0.900),敏感度95.2%-99.1%、阴性预测值96.4%-99.5%,但特异度65.0%-68.6%、阳性预测值53.7%-61.9%相对较低;部分X线征象观察者间一致性较低,作者认为共识性评分系统需进一步研究并可能更新。

要点

  • Bone-RADS点总分与分类对附肢骨恶性肿瘤的AUC分别为0.940-0.957与0.895-0.900。
  • Bone-RADS敏感度95.2%-99.1%、阴性预测值96.4%-99.5%,特异度65.0%-68.6%、阳性预测值53.7%-61.9%相对较低。
  • 骨内膜侵蚀(k=0.537)与骨外肿块(k=0.234)的观察者间一致性较低。

核心结论

  • 在附肢骨恶性肿瘤诊断中,ACR Bone-RADS表现出高鉴别能力、高敏感度和高阴性预测值,但特异度和阳性预测值相对较低;部分X线征象观察者间一致性较低及Bone-RADS基于共识的评分系统需进一步研究并可能更新。

研究设计与样本

  • 诊断准确性研究,纳入778例(良性507例、中间型45例、恶性226例)接受X线和MRI检查的附肢骨原发及继发肿瘤患者,以组织病理学、影像随访或临床-放射学共识为参考标准,由两位放射科医生评估5项X线征象并计算点总分和Bone-RADS分类。

诊断标准与关键数值

  • Bone-RADS基于边缘、骨膜反应、骨内膜侵蚀、病理性骨折和骨外肿块5项X线征象及癌症病史计算点总分并分类;点总分AUC 0.940-0.957,分类AUC 0.895-0.900,敏感度95.2%-99.1%,阴性预测值96.4%-99.5%,特异度65.0%-68.6%,阳性预测值53.7%-61.9%;点总分ICC=0.850,分类k=0.739,多数X线征象k=0.621-0.822,骨内膜侵蚀k=0.537,骨外肿块k=0.234。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 部分X线征象(骨内膜侵蚀k=0.537、骨外肿块k=0.234)观察者间一致性相对较低。
  • Bone-RADS采用基于共识的评分系统,需进一步研究并可能更新。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the diagnostic performance of the American College of Radiology(ACR) Bone Reporting and Data System (Bone-RADS) in diagnosis of malignant tumors of the appendicular bone on conventional radiographs.

METHODS: Primary and secondary tumors of appendicular bone in patients who underwent radiographic and MRI examinations were classified into benign, intermediate, and malignant using a reference standard of histopathology, imaging follow-up, or clinical-radiologic consensus. Two radiologists assessed five radiographic features (margin, periosteal reaction, endosteal erosion, pathologic fracture, and extra-osseous mass), scored point total (points from radiographic features and a history of cancer), and assigned Bone-RADS categories. The diagnostic performance of Bone-RADS and interreader agreements were calculated.

RESULTS: A total of 778 patients (507 benign, 45 intermediate, and 226 malignant tumors) were included. Bone-RADS showed high discrimination performance, with areas under the receiver-operating characteristics curve of 0.940-0.957 for point total and 0.895-0.900 for categorization. Bone-RADS had high sensitivity (95.2 %-99.1 %) and negative predictive value (NPV) (96.4 %-99.5 %), but relatively low specificity (65.0 %-68.6 %) and positive predictive value (PPV) (53.7 %-61.9 %). Interreader agreements were good to excellent for Bone-RADS point total (ICC = 0.850), categorization (k = 0.739), and most of the radiographic features (k = 0.621-0.822), except for endosteal erosion (k = 0.537) and extra-osseous mass (k = 0.234).

CONCLUSION: In diagnosis of malignant bone tumors, ACR Bone-RADS showed high discrimination performance, with high sensitivity and NPV, but relatively low specificity and PPV. Nevertheless, relatively low interobserver agreement in some radiographic features and the consensus-based points system in Bone-RADS warrant further research and possible updates.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Park SY, Yoon MA, Lee MH, et al. Validation of American College of Radiology Bone Reporting and Data System (Bone-RADS) Version 2023 for diagnosis of malignant tumors of appendicular bone on conventional radiographs. Eur J Radiol. 2024. PMID: 39637582. doi:10.1016/j.ejrad.2024.111861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。